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Background
Type 2 diabetes is characterized by insulin resistance in
various insulin target cells, such as hepatocytes, myo-
blasts and adipocytes [1]. The recent realization that the
osteoblast is an insulin target cell involved in the control
of whole-body glucose homeostasis [2] suggests the pos-
sibility that impaired insulin signaling in osteoblasts
contributes to the development of type 2 diabetes.
Materials and methods
All mice were fed a high fat diet (60%kcal%fat) for 8
weeks to induce diabetes. To examine insulin signaling
in bones, phosphorylation levels of InsR at Tyr1150/
1151, AKT at Thr308 and Ser473 and GSK-3-b at Ser9
were determined by Western blots. Glucose metabolism
and insulin sensitivity were determined by Glucose tol-
erance test (GTT) and Insulin tolerance tests (ITT).
Serum levels of insulin, osteocalcin and bone resorption
marker Ctx were measured by ELISA.
Results
To determine whether bone is a site of insulin resis-
tance, we first examined insulin signaling in bone tissues
of WT mice fed a high fat diet (HFD) and observed that
levels of insulin receptor, insulin-induced phosphoryla-
tion of insulin receptor at Tyr1150/1151, of AKT at
Thr308 and Ser473, and of GSK-3-b at Ser9, were mark-
edly decreased. More importantly, several insulin-depen-
dent functions taking place in osteoblasts were
disrupted in mice rendered diabetics through HFD: (1)
bone resorption was decreased as reflected by reduced
level of serum Ctx. (2) expression of Opg, an insulin tar-
get gene in osteoblast, was increased by 2 fold compared
to control mice. (3) circulating levels of active osteocal-
cin (Glu13-Ocn) was decreased in HFD-fed mice. In
addition, ex vivo treatment of primary osteoblasts with
palmitate, one of the most abundant dietary saturated
fatty acid causing insulin resistance in various insulin
target cells, also significantly impaired insulin signaling,
as shown by decreased levels of insulin receptor and
insulin stimulated phospho-AKT. Lastly, to test If insu-
lin resistance in osteoblasts contribute to the systematic
insulin resistance, we used loss-of (InsRosb+/-) and gain-
of function (a1(I)Col-InsR) models of insulin signaling
in osteoblasts. Although showing normal glucose meta-
bolism when fed on normal diet, InsRosb+/- mice devel-
oped more severe insulin resistance in comparison to
control mice fed the same HFD as evidenced by higher
levels of blood glucose and serum insulin, decreased
ability to clear glucose in GTT and more resistance to
insulin in ITT. Conversely, a1(I)Col-InsR mice fed on
HFD were less hyperglycemic, less hyperinsulinemic,
more glucose tolerance and more insulin sensitive than
control mice.
Conclusions
Taken together, this study provided evidence that insu-
lin resistance takes place in bones in diet-induced type 2
diabetes model and insulin resistance in osteoblasts con-
tributes to the development of systematic insulin resis-
tance in type 2 diabetes.
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